1004536

Boehringer Ingelheim Pharmaceuticals, Inc. — FEI 1219205

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 28, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Ridgefield, CT (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
748221 CFR 312.50General responsibilities of sponsors